MedPath

King's College London

King's College London logo
🇸🇪Sweden
Ownership
Private
Established
1829-01-01
Employees
5K
Market Cap
-
Website
http://www.kcl.ac.uk

AI-Guided Drug Discovery Identifies Promising Cancer Treatment Combinations Using Existing Non-Cancer Medications

University of Cambridge researchers used GPT-4 to identify drug combinations that could treat cancer, finding that three of 12 AI-suggested combinations outperformed current breast cancer drugs in laboratory tests.

Safety Concerns Emerge for Gold-Based Cisplatin Mimics in Cancer Treatment Development

Researchers from King's College London and Jagannath University discovered that gold-based cisplatin mimics contain a mixture of potentially dangerous isomers rather than a pure compound as previously believed for over 60 years.

Mindfulness-Based Cognitive Therapy Shows Promise for Treatment-Resistant Depression

A new clinical trial published in Lancet Psychiatry demonstrates that mindfulness-based cognitive therapy (MBCT) significantly improves symptoms in patients with difficult-to-treat depression compared to standard care.

Ubrogepant Shows Promise in Treating Migraine Prodromal Symptoms in Phase III Trial

A phase III clinical trial reveals that ubrogepant, an approved migraine medication, can effectively alleviate debilitating prodromal symptoms like fatigue, light sensitivity, and concentration difficulties that precede migraine headaches.

New Bone Marrow Test Could Double Survival Rates for Acute Myeloid Leukemia Patients

A groundbreaking UK trial has developed a highly sensitive bone marrow test that can detect returning Acute Myeloid Leukemia up to three months earlier than standard blood tests, potentially doubling survival rates for some patients.

Wegovy Shows Promise in Treating MASH, a Serious Liver Disease

A landmark Phase 3 clinical trial led by VCU and King's College London researchers found semaglutide significantly reduces liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Lupus Research Alliance Awards $4.5 Million to Pioneer Next-Generation Cell Therapies for Lupus

The Lupus Research Alliance has launched its Targeted Research Program on Engineered Cell Therapies for Lupus (TRP-ECT), awarding grants to 11 researchers developing innovative cellular treatments.

NHS Launches £10 Million Clinical Trial on Puberty Blockers Following Cass Review Recommendations

The NHS has approved a £10.7 million clinical trial to investigate the potential benefits of puberty blockers for young people with gender dysphoria, following recommendations from Baroness Cass's comprehensive review.

JAK Inhibitors Reduce Thromboembolic Risk in Myeloproliferative Neoplasms Through Novel Mechanisms

A meta-analysis of 23 publications involving 2,198 patients demonstrated that JAK inhibitors significantly reduce thromboembolic events by 48% in myeloproliferative neoplasm patients, with ruxolitinib showing a 59% reduction in polycythemia vera and myelofibrosis.

Medtronic's GI Genius AI System Enters Large-Scale NAIAD Clinical Trial for Enhanced Colorectal Cancer Detection

Medtronic's GI Genius, an AI-powered tool, aims to improve the detection of precancerous lesions during colonoscopy screenings, crucial for early colorectal cancer treatment.

© Copyright 2025. All Rights Reserved by MedPath